Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Kengo Isshiki
CEO | Chief Executive Officer | - | 01.01.20 |
Director of Finance/CFO | - | 01.01.20 | |
Ofer Ekbali
COO | Chief Operating Officer | - | 01.04.20 |
Uri David
CTO | Chief Tech/Sci/R&D Officer | 98 | 01.10.19 |
Anat Nahmany
HRO | Human Resources Officer | - | 01.01.16 |
Ziva Mesika
LAW | General Counsel | 60 | 01.07.16 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Chairman | - | 01.04.20 | |
Mikio Himizu
BRD | Director/Board Member | - | 01.10.17 |
Hitoshi Izaki
BRD | Director/Board Member | - | 01.05.20 |
Kenji Taguchi
BRD | Director/Board Member | - | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 26 345 938 | 17 477 028 ( 66,34 %) | 0 | 66,34 % |
Unternehmenskontakt
NeuroDerm Ltd.
Ruhrberg Science Building Bell Entrance, Rabin Science Park
7670212, Rehovot
+972 8 946 2729
http://www.neuroderm.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+5,33 % | 111 Mrd. | |
+12,11 % | 106 Mrd. | |
-12,56 % | 22,24 Mrd. | |
-3,46 % | 21,25 Mrd. | |
-5,61 % | 18,97 Mrd. | |
-35,21 % | 18,52 Mrd. | |
-10,86 % | 16,81 Mrd. | |
+37,57 % | 12,54 Mrd. | |
-26,24 % | 8,09 Mrd. |